Key result
Drug treatment of mild hypertension (140-159/90-99 mm Hg) in people without higher risks of diabetes or chronic kidney disease provides no net benefit, highlighting potential overtreatment.
Why the study?
Do antihypertensive drugs provide net benefit in people with mild hypertension without diabetes or chronic kidney disease?
Population
People with mild hypertension (140-159/90-99 mm Hg) without higher risks of diabetes or chronic kidney disease
Design
Review
Authors
Loading...
Supports withholding drugs in low-risk mild hypertension; leaves open need for definitive RCTs before practice change.
Do antihypertensive drugs provide net benefit in people with mild hypertension without diabetes or chronic kidney disease?
The article highlights the potential overdiagnosis and overtreatment of mild hypertension in low-risk individuals, where evidence suggests no net benefit from drug therapy.
Martin et al. (2014) conducted a review in Mild hypertension. Antihypertensive drugs was evaluated. Drug treatment of mild hypertension (140-159/90-99 mm Hg) in people without higher risks of diabetes or chronic kidney disease provides no net benefit, highlighting potential overtreatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: